Skip to main content
A

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 252 across all filing types
Latest filing 2025-10-01 Regulatory Filings
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
주요사항보고서(자본으로인정되는채무증권발행결정)
Regulatory Filings
2025-10-01 Korean
주요사항보고서(유상증자결정)
Regulatory Filings
2025-10-01 Korean
주요사항보고서(전환사채권발행결정)
Regulatory Filings
2025-10-01 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a formal announcement of a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) between AbClon and the Korea Disease Control and Prevention Agency. It details the contract value, duration, and terms. Since this is a specific regulatory disclosure regarding a business contract that does not fit into financial reporting or other specific categories like M&A or dividends, it falls under the general regulatory filing category.
2025-08-27 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-annual Report) for AbClon Inc., covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, management history, capital structure, and business descriptions, which are characteristic of a comprehensive interim financial report. It is not a mere announcement or certification, but the full report itself. H1 2025
2025-08-13 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from a Korean company (AbClon) regarding a 'Single Sales/Supply Contract' amendment. It details a contract extension due to supply chain delays and provides specific contract terms, amounts, and counterparty information. Since this is a specific regulatory disclosure regarding a contract amendment and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2025-08-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.